Radar › Companies › Cannabis HealthTech · England
Radar · Cannabis HealthTech in England

Best Cannabis HealthTech Companies in England, United Kingdom

The 65 best Cannabis HealthTech companies in England, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Emmac.

65companies tracked
$149Mdisclosed funding
0unicorns
10have raised

Ranked: Best Cannabis HealthTech companies in England

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackRecent signals
1Emmac
Cultivator and producer of medical cannabis products
$69M66 mo agoAcquiredMatthew Darin Darin
CEO
2018——
2GW Pharma
Developer of cannabinoid medicines for MS spasticity, cancer pain and childhood epilepsy
$46M111 mo agoAcquired—1998——
3Grow Group
Developer of cannabis-based medicines for multiple indications
$13M57 mo agoSeries CBen Langley
Co-Founder & Chief Executive Officer
2017WordPressMySQLPHP+14—
4Grow Group
Developer of cannabis-based therapeutic for multiple diseases
$8M67 mo agoDeadpooledBenjamin Langley
Co-Founder & CEO
———
5Alphargreen Group Limited
Provider of an online market place of cannabis products for various diseases
$5M61 mo agoSeedAlexej Pikovsky
Co-Founder & CEO
2019——
6Alterola Biotech
Developer of cannabis-derived therapeutics for multiple indications
$4M44 mo agoPublicBarrett Evans
CEO & MD
2021——
7Hilltop Leaf
Provider of hemp-based wellness products to improve health
$2M41 mo agoSeed—2019——
8South West Brands
Producer of multi-brand consumer goods focused on wellness and lifestyle
$665K46 mo agoAcquired—2020——
9hapac
Provider of smart devices for cannabis dose management
$601K92 mo agoSeedDomenico Ventura
CEO
2017——
10Releaf
Provider of medical cannabis card to access cannabis treatment and products
$270K33 mo agoSeedMason Soiza
Founder
2022DatoCMSApple iCloud MailGoogle Workspace+211 partnership

Top 11 Cannabis HealthTech companies in England

#1
Acquired · London, England · founded 2018 · 187 employees
$69.1Mraised
▾

Cultivator and producer of medical cannabis products. The company's product offerings include CBD products, cannabinoids, hemp extracts, and other cannabis-derived products. It is engaged in the research & development, cannabis cultivation, production, and distribution of cannabis products.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 17k LinkedIn followers — 38.0% of this cohort's audience
Funding rounds
  • Dec 2020Series D$20.1M
  • Jan 2020Series C$5.3M
  • Oct 2019Series C$19M
  • Jun 2019Series B$2.4M
Founders & team
Matthew Darin DarinCEO
Investors
Altitude Investment Management, Fastforward Innovations, Measure 8 Ventures Management, ENEXIS, Bloom Ventures, GROWNEXOTICSCANNABIS
#2
Seed · Nottingham, England · founded 2022
$270.2Kraised
▾

Provider of medical cannabis card to access cannabis treatment and products. It offers subscription model that allow patients with cannabis consultation, treatment, and medicines.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 10k LinkedIn followers — 23.8% of this cohort's audience
Activity: 1 partnerships (incl. Glas Pharms) announced in 12 mo
Funding rounds
  • Sep 2023Seed$270.2K
Founders & team
Mason SoizaFounder
Tech stack
AdformAlgoliaAmazon S3Amazon Web ServicesApple Icloud MailAstro
#3
Seed · London, England · founded 2019 · 5 employees
$2.4Mraised
▾

Provider of hemp-based wellness products to improve health. The products include oils, capsules, topical, and transdermal patches. These products help in reducing pain, sleep disorders, stress, and depression, and improve homeostasis.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers — 3.1% of this cohort's audience
Funding rounds
  • Jan 2023Seed$2.4M
Investors
Traditum
#4
Public · Birkenhead, England · founded 2021 · 1 employees
$4Mraised
▾

Developer of cannabis-derived therapeutics for multiple indications. The company's drug pipeline candidates including cannabinoid-like, and non-cannabinoid pharmaceutical medicines, which are under development for a range of indications. Also, it has developed nano-technology-based drug delivery formulations.

Funding rounds
  • Oct 2022Post IPO$4M
Founders & team
Barrett EvansCEO & MD
Investors
Bright Green
#5
Series C · London, England · founded 2017 · 13 employees
$12.6Mraised
▾

Developer of cannabis-based medicines for multiple indications. The company discovers and develops cannabis-based medicine to treat chronic pain such as neuropathic pain, cancer pain, epileptic seizures, spasticity, and drug addictions. Also, provide Calyx app to track health, medicine, and activities.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers — 9.7% of this cohort's audience
Funding rounds
  • Aug 2021Series C$4.7M
  • Nov 2020Series C$7.9M
Founders & team
Ben LangleyCo-Founder & Chief Executive Officer
#6
Acquired · London, England · founded 2020 · 12 employees
$665.2Kraised
▾

Producer of multi-brand consumer goods focused on wellness and lifestyle. The company develops brands intended to bring cannabis into the mainstream market. The company's platform focuses on creating purpose-led brands with integrity.

Funding rounds
  • Aug 2022Seed$60.3K
  • Oct 2021Seed$203.2K
  • Jul 2021Seed$59.2K
  • Feb 2021Seed$342.5K
Investors
SEED Innovations, Fastforward Innovations, ENEXIS
#7
Seed · Covent Garden, England · founded 2019 · 5 employees
$4.9Mraised
▾

Alphargreen Group Limited is a provider of an online marketplace of cannabis products for various diseases. It provides various cannabis products for multiple diseases like stress & anxiety, sleep, mood, pain & injury, beauty, intimacy, superfood, and many more. It also offers cannabis medical products for pet health.

Funding rounds
  • Apr 2021Seed$2.7M
  • Nov 2020Seed$1.5M
  • Mar 2020Seed$652.5K
Founders & team
Alexej PikovskyCo-Founder & CEO
Investors
ENEXIS, Firestartr, OOTWI
#8
Acquired · Cambridge, England · founded 1998 · 326 employees
$46.5Mraised
▾

Developer of cannabinoid medicines for MS spasticity, cancer pain, and childhood epilepsy. The drugs include Sativex for the treatment of MS spasticity and cancer pain and Epidiolex for the treatment of childhood epilepsy. Sativex is indicated as a treatment for symptom improvement in patients with moderate to severe spasticity due to multiple sclerosis.

Funding rounds
  • Mar 2017Post IPO$1M
  • Jan 2006Series C$15M
  • Jun 2003Series C$31.5M
Investors
Mentor Capital, Reqcap, New Leaf Capital, Great Point Partners, Treehouse Global Ventures, Venrock
Tech stack
WordpressMysqlPhpW3 Total CacheTablepressYoast Seo
#9
Deadpooled · London, England
$7.9Mraised
▾

Developer of cannabis-based therapeutic for multiple diseases

Founders & team
Benjamin LangleyCo-Founder & CEO
#10
Seed · Brentwood, England · founded 2017 · 2 employees
$601.4Kraised
▾

Hapac is a provider of smart devices for cannabis dose management. It is a small, ready to use packs of pre-ground medicinal cannabis designed for use in portable inhalers. It provides a measured dose and are simple and easy to use. It reduced toxicants and no pungent, indiscreet smoke, and many more.

Funding rounds
  • Sep 2018Seed$601.4K
Founders & team
Domenico VenturaCEO
Investors
Ananda Developments
#11
Public · Oxford, England · founded 2017 · 1 employees
—raised
▾

Developer of cannabinoid-based therapies. The company is working towards finding cannabinoid-based therapies for inflammatory diseases, cancer, neurological disorders, and pain management.

Funding rounds
  • Mar 2017Series A—
Investors
Kingsley Capital Partners, Casa Verde Capital

Funding & investor landscape

$149Mtotal disclosed funding
10companies funded
22disclosed rounds
0rounds last 90 days
Most active investors
ENEXIS3 rounds
Fastforward Innovations2 rounds
Acorn Bioventures1 rounds
Altitude Investment Management1 rounds
Ananda Developments1 rounds
Artemis Growth Partners1 rounds
Bloom Ventures1 rounds
Bondeinvest.com1 rounds
Bright Green1 rounds
Casa Verde Capital1 rounds

Notable founders

Matthew Darin Darin
CEO · Emmac
Mason Soiza
Founder · Releaf
Barrett Evans
CEO & MD · Alterola Biotech
Ben Langley
Co-Founder & Chief Executive Officer · Grow Group
Alexej Pikovsky
Co-Founder & CEO · Alphargreen Group Limited
Benjamin Langley
Co-Founder & CEO · Grow Group
Domenico Ventura
CEO · hapac
Prism market signals · United Kingdom · country-scoped Prism corpus, 528,645 docs

Market landscape — 10 sub-themes by coverage

Share of Cannabis HealthTech coverage by sub-theme.

Regulatory-risk over time flat

Funding & growth over time

funding rising · growth rising

Common questions

How many Cannabis HealthTech companies are there in England, United Kingdom?
Radar tracks 65 indexable Cannabis HealthTech companies headquartered in England, United Kingdom that meet our profile-completeness bar.
What is the total funding raised by Cannabis HealthTech companies in England, United Kingdom?
The Cannabis HealthTech companies in England, United Kingdom on this list have raised a combined $149M in disclosed equity funding across 10 funded companies.
Which is the highest-funded Cannabis HealthTech company in England, United Kingdom?
Emmac is the highest-funded Cannabis HealthTech company in England, United Kingdom, with $69.1M in disclosed equity funding.
How many Cannabis HealthTech companies in England, United Kingdom are funded?
10 of the 65 Cannabis HealthTech companies in England, United Kingdom on this list have disclosed at least one equity funding round.
How many Cannabis HealthTech unicorns are there in England, United Kingdom?
None of the Cannabis HealthTech companies in England, United Kingdom on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in England, United Kingdom Cannabis HealthTech companies?
The most active investors in England, United Kingdom Cannabis HealthTech companies on this list include ENEXIS, Fastforward Innovations, Acorn Bioventures, Altitude Investment Management, Ananda Developments.
Riya SenguptaFinancials

Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.

Coming soon